Members Login
Channels
Special Offers & Promotions
Save Samples, Time and Money with BioTek's New Take3 Trio Micro-Volume Plate
publication date: Sep 29, 2011
|
author/source: BioTek Instruments
BioTek introduces the new Take3TM Trio, the first micro-volume, high
density plate for convenient and rapid nucleic acid and protein quantification
without sample dilution. Take3 Trio is capable of measuring up to forty-eight 2
μL samples.
Microliter samples are pipetted onto specially coated slides that are simply wiped clean after the samples are read for simple maintenance. Take3 Trio and the original Take3 Micro-Volume Plate are compatible with most of BioTek's microplate readers, including their newest EonTM Microplate Spectrophotometer. Gen5TM Data Analysis Software contains pre-programmed Take3 Trio protocols, and allows spectral scanning, sample naming and parallel reading of samples and blanks.
BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to aid in the advancement of life science research, facilitate the drug discovery process and to enable cost-effective quantification of disease relevant molecules in the clinic.
Microliter samples are pipetted onto specially coated slides that are simply wiped clean after the samples are read for simple maintenance. Take3 Trio and the original Take3 Micro-Volume Plate are compatible with most of BioTek's microplate readers, including their newest EonTM Microplate Spectrophotometer. Gen5TM Data Analysis Software contains pre-programmed Take3 Trio protocols, and allows spectral scanning, sample naming and parallel reading of samples and blanks.
BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to aid in the advancement of life science research, facilitate the drug discovery process and to enable cost-effective quantification of disease relevant molecules in the clinic.
Media Partners